| David R Mack, MD | |
|
505 W Northern Lights Blvd, Anchorage, AK 99503-2552 | |
| (907) 302-8205 | |
| Not Available |
| Full Name | David R Mack |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 23 Years |
| Location | 505 W Northern Lights Blvd, Anchorage, Alaska |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811041056 | NPI | - | NPPES |
| 13580 | Medicaid | NC | |
| P00230275 | Other | ND | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MEDS 7369 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Seward Hospital | Seward, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seaview Community Services | 5597656025 | 2 |
| Wisdom Traditions Counseling Services Llc | 2567794217 | 2 |
News Archive
A national movement to eliminate non-medically indicated (NMI) delivery before 39 weeks has prompted nearly two-thirds of all U.S. hospitals handling non-emergency births to adopt specific policies against the practice, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage.
Accelerate Cambridge and DigitalHealth.London launchpad company Medwise.ai announces it was selected from over 8600 applications to receive funding by the UK Government to develop an AI-powered platform that answers COVID-19 questions for healthcare professionals.
The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
› Verified 8 days ago
| Entity Name | State Of Alaska Department Of Administration |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497842553 PECOS PAC ID: 5395638571 Enrollment ID: O20040203000267 |
News Archive
A national movement to eliminate non-medically indicated (NMI) delivery before 39 weeks has prompted nearly two-thirds of all U.S. hospitals handling non-emergency births to adopt specific policies against the practice, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage.
Accelerate Cambridge and DigitalHealth.London launchpad company Medwise.ai announces it was selected from over 8600 applications to receive funding by the UK Government to develop an AI-powered platform that answers COVID-19 questions for healthcare professionals.
The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
› Verified 8 days ago
| Entity Name | Seaview Community Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639263510 PECOS PAC ID: 5597656025 Enrollment ID: O20040323001247 |
News Archive
A national movement to eliminate non-medically indicated (NMI) delivery before 39 weeks has prompted nearly two-thirds of all U.S. hospitals handling non-emergency births to adopt specific policies against the practice, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage.
Accelerate Cambridge and DigitalHealth.London launchpad company Medwise.ai announces it was selected from over 8600 applications to receive funding by the UK Government to develop an AI-powered platform that answers COVID-19 questions for healthcare professionals.
The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
› Verified 8 days ago
| Entity Name | Wisdom Traditions Counseling Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467775676 PECOS PAC ID: 2567794217 Enrollment ID: O20191029002982 |
News Archive
A national movement to eliminate non-medically indicated (NMI) delivery before 39 weeks has prompted nearly two-thirds of all U.S. hospitals handling non-emergency births to adopt specific policies against the practice, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage.
Accelerate Cambridge and DigitalHealth.London launchpad company Medwise.ai announces it was selected from over 8600 applications to receive funding by the UK Government to develop an AI-powered platform that answers COVID-19 questions for healthcare professionals.
The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David R Mack, MD 505 W Northern Lights Blvd, Anchorage, AK 99503-2552 Ph: (907) 302-8205 | David R Mack, MD 505 W Northern Lights Blvd, Anchorage, AK 99503-2552 Ph: (907) 302-8205 |
News Archive
A national movement to eliminate non-medically indicated (NMI) delivery before 39 weeks has prompted nearly two-thirds of all U.S. hospitals handling non-emergency births to adopt specific policies against the practice, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage.
Accelerate Cambridge and DigitalHealth.London launchpad company Medwise.ai announces it was selected from over 8600 applications to receive funding by the UK Government to develop an AI-powered platform that answers COVID-19 questions for healthcare professionals.
The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.
› Verified 8 days ago
Daniel Gregory Allen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 673 Medical Group, Jb Elmendorf-richardson, Anchorage, AK 99506 Phone: 907-580-2181 | |
Robert D Wald, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2605 Denali St, Ste 203, Anchorage, AK 99503 Phone: 907-677-9253 Fax: 907-272-1553 | |
Dr. Sheila Joyce Clark, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 207 E Northern Lights Blvd, Ste 111, Anchorage, AK 99503 Phone: 907-272-1892 Fax: 907-272-0962 | |
Dr. David Michael Henzler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dimond Blvd, Anchorage, AK 99515 Phone: 907-565-6000 Fax: 907-565-6001 | |
Dr. Karen Jackman, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1675 C St, Suite 117, Anchorage, AK 99501 Phone: 907-274-8281 Fax: 907-274-4055 | |
Dr. Steven Edward Koehl, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-2181 | |
Dr. Cathleen E Marshall, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr Ste A565, Anchorage, AK 99508 Phone: 907-212-2321 Fax: 907-212-8499 |